Antibody response to enterotoxigenic Bacteroides fragilis of Filipino colorectal cancer patients

[1] Dejea C, Wick E, Sears CL. Bacterial oncogenesis in the colon. Future Microbiol. 2013; 8:445–60. DejeaC WickE SearsCL. Bacterial oncogenesis in the colon Future Microbiol. 2013 8 445 60 Search in Google Scholar

[2] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394–424. BrayF FerlayJ SoerjomataramI SiegelRL TorreLA JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin. 2018 68 394 424 Search in Google Scholar

[3] Afinidad-Bernardo D. Colorectal cancer now Philippines’ number 1 cancer [Internet]. 2021 [cited 2021 Dec 21]. Available from: https://www.philstar.com/lifestyle/health-and-family/2017/03/08/1677440/colorectal-cancer-now-philippines-number-1-cancer. [Retrieved 2021 Dec 21]. Afinidad-BernardoD. Colorectal cancer now Philippines’ number 1 cancer [Internet] 2021 [cited 2021 Dec 21]. Available from: https://www.philstar.com/lifestyle/health-and-family/2017/03/08/1677440/colorectal-cancer-now-philippines-number-1-cancer. [Retrieved 2021 Dec 21]. Search in Google Scholar

[4] Purcell RV, Pearson J, Aitchison A, Dixon L, Frizelle FA, Keenan JI. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. PLoS One. 2017; 12:e0171602. doi: 10.1371/journal.pone.0171602 PurcellRV PearsonJ AitchisonA DixonL FrizelleFA KeenanJI. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia PLoS One. 2017 12 e0171602 10.1371/journal.pone.0171602 Open DOISearch in Google Scholar

[5] Sears CL. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev. 2009; 22:349–69. SearsCL. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes Clin Microbiol Rev. 2009 22 349 69 Search in Google Scholar

[6] Wu S, Lim KC, Saidi RF, Sears CL. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci U S A. 1998; 95:14979–84. WuS LimKC SaidiRF SearsCL. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin Proc Natl Acad Sci U S A. 1998 95 14979 84 Search in Google Scholar

[7] Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 2003; 124:392–400. WuS MorinPJ MaouyoD SearsCL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation Gastroenterology. 2003 124 392 400 Search in Google Scholar

[8] Rhee KJ, Wu S, Wu X, Huso DL, Karim B, Franco AA, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009; 77:1708–18. RheeKJ WuS WuX HusoDL KarimB FrancoAA Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice Infect Immun. 2009 77 1708 18 Search in Google Scholar

[9] Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, Lazarev MG, et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis. 2015; 60:208–15. BoleijA HechenbleiknerEM GoodwinAC BadaniR SteinEM LazarevMG The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients Clin Infect Dis. 2015 60 208 15 Search in Google Scholar

[10] Viljoen KS, Dakshinamurthy A, Goldberg P, Blackburn JM. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS One. 2015; 10:e0119462. doi: 10.1371/journal.pone.0119462 ViljoenKS DakshinamurthyA GoldbergP BlackburnJM. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer PLoS One. 2015 10 e0119462 10.1371/journal.pone.0119462 Open DOISearch in Google Scholar

[11] von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008; 61:344–49. von ElmE AltmanDG EggerM PocockSJ GøtzschePC VandenbrouckeJP STROBE Initiative The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies J Clin Epidemiol. 2008 61 344 49 Search in Google Scholar

[12] Frey A, Di Canzio J, Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods. 1998; 221:35–41. FreyA Di CanzioJ ZurakowskiD. A statistically defined endpoint titer determination method for immunoassays J Immunol Methods. 1998 221 35 41 Search in Google Scholar

[13] Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009; 15:1016–22. WuS RheeKJ AlbesianoE RabizadehS WuX YenHR A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses Nat Med. 2009 15 1016 22 Search in Google Scholar

[14] Magat EM, Balanag GA, Cariño AM, Fellizar A, Ortin TS, Guevarra L Jr, Albano PM. Clostridioides difficile antibody response of colorectal cancer patients versus clinically healthy individuals. Biosci Microbiota Food Health. 2020; 39:123–7. MagatEM BalanagGA CariñoAM FellizarA OrtinTS GuevarraLJr AlbanoPM. Clostridioides difficile antibody response of colorectal cancer patients versus clinically healthy individuals Biosci Microbiota Food Health. 2020 39 123 7 Search in Google Scholar

[15] Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012; 10:575–82. TjalsmaH BoleijA MarchesiJR DutilhBE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects Nat Rev Microbiol. 2012 10 575 82 Search in Google Scholar

[16] Lee KH, Shim KS, Lim IS, Chae SA, Yun SW, Lee NM, et al. Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea. BMC Pediatr. 2017; 17:164. doi: 10.1186/s12887-017-0924-7 LeeKH ShimKS LimIS ChaeSA YunSW LeeNM Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea BMC Pediatr. 2017 17 164 10.1186/s12887-017-0924-7 Open DOISearch in Google Scholar

[17] Bio-rad. Helpful ELISA hints [Internet]. 2021 [cited 2021 July 20]. Available from: https://www.bio-rad-antibodies.com/helpful-elisa-hints.html. Bio-rad Helpful ELISA hints [Internet] 2021 [cited 2021 July 20]. Available from: https://www.bio-rad-antibodies.com/helpful-elisa-hints.html. Search in Google Scholar

[18] Guevarra LA Jr, Afable ACF, Belza PJO, Dy KJS, Lee SJQ, Sy-Ortin TT, Albano PMSP. Immunogenicity of a Fap2 peptide mimotope of Fusobacterium nucleatum and its potential use in the diagnosis of colorectal cancer. Infect Agent Cancer. 2018; 13:11. doi: 10.1186/s13027-018-0184-7 GuevarraLAJr AfableACF BelzaPJO DyKJS LeeSJQ Sy-OrtinTT AlbanoPMSP. Immunogenicity of a Fap2 peptide mimotope of Fusobacterium nucleatum and its potential use in the diagnosis of colorectal cancer Infect Agent Cancer. 2018 13 11 10.1186/s13027-018-0184-7 Open DOISearch in Google Scholar

[19] Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009; 22:191–7. HaggarFA BousheyRP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors Clin Colon Rectal Surg. 2009 22 191 7 Search in Google Scholar